亚洲欧美日韩制服在线-手机在线看黄AV免费-国内精品久久久久影视-成人久久免费网站-亚洲av永久无码天堂影院-一本无码中文字幕免费播互動交流-福利一区二区三区不卡视频-18岁以下禁止进入国产一区-久久久精品2019中文字幕cms-久久综合天堂AV

利拉利汀雜質對照品
提供NMR，HPLC，MS圖譜及COA證書，新藥申報可用
Linagliptin Impurity
全部雜質現貨供應，*，并可接受定制。

利拉利汀雜質對照品? 產品介紹：
規格：10mg/25mg/50mg/100mg等多種規格可選。
用途：實驗研發，藥品申報檢測，不得用于臨床醫學診斷。
隨貨提供：所有雜質對照品均隨貨提供HPLC，NMR，MS圖譜及CoA證書。

國產進口品牌皆有銷售，產品庫時常會有更新，另外，我司有專業研發團隊，可提供部分雜質定制服務，以zui大可能的滿足您雜質對照品的選購需求。

利拉利汀雜質對照品 雜質列表：

Linagliptin	(R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 1	7-(but-2-yn-1-yl)-8-((2-hydroxyethyl)amino)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 2	2-((R)-3-aminopiperidine-1-carbonyl)-N-((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)benzamide
Linagliptin Impurity 3	(R)-7-(but-2-yn-1-yl)-8-(3-(1,3-dioxoisoindolin-2-yl)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 4	(R,Z)-8-(3-aminopiperidin-1-yl)-7-(3-bromobut-2-en-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 5	N1,N2-bis((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)phthalamide
Linagliptin Impurity 6	(R)-2-((1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamoyl)benzoic acid
Linagliptin Impurity 7	8-((R)-3-aminopiperidin-1-yl)-7-((R)-buta-1,2-dien-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione compound with 8-((R)-3-aminopiperidin-1-yl)-7-((S)-buta-1,2-dien-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione (1:1)
Linagliptin Impurity 8	(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)acetamide
Linagliptin Impurity 9	8-bromo-1,7-di(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 10	(R)-tert-butyl (1-(1,7-di(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
Linagliptin Impurity 11	(R)-8-(3-aminopiperidin-1-yl)-1,7-di(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 12	8-bromo-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 13	(R)-tert-butyl (1-(3-methyl-7-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
Linagliptin Impurity 14	(R)-8-(3-aminopiperidin-1-yl)-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 15	(R)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-8-(piperidin-3-ylamino)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 16	(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroacetamide
Linagliptin Impurity 17	(S)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 18	7-(but-2-yn-1-yl)-8-(dimethylamino)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 19	N-(2-acetylphenyl)-2-(8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide
Linagliptin Impurity 20	(R)-tert-butyl (1-(1-(2-((2-acetylphenyl)amino)-2-oxoethyl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
Linagliptin Impurity 21	(R)-N-(2-acetylphenyl)-2-(8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide
Linagliptin Impurity 22	(R)-tert-butyl (1-(7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
Linagliptin Impurity 23	(R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 24	(S)-tert-butyl (1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
Linagliptin Impurity 25	(R)-7-(but-2-yn-1-yl)-8-(3-((7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)amino)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 26	(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)formamide

除自主雜質對照品品牌外，我司優勢代理多個進口雜質品牌:EP，USP，JP，LGC,TRC，TLC，Molcan等，*滿足您對雜質對照品的需求。另代理意大利Chromogenix肝素檢測試劑，英國NIBSC標準試劑，Sigma-Aldrich試劑, 美國ChromaDex中草藥標準品，瑞士CaroteNature類胡蘿卜素標準品，法國Extrasynthese中草藥標準品，WHO世界衛生組織藥物標準品，NIST美國國家標準局標準品，IRRM歐洲標準局標準品等各種標準品，CIL美國劍橋同位素標準品，種類齊全，到貨迅速。

美國CIL標準品部分產品列表：

ULM-9123-0.005 VITAMIN B2 (RIBOFLAVIN) UNLABELED (CHEM. PURITY 97%)

DLM-380-PK STYRENE (D8, 98%) + BHT

NLM-647-PK L-ASPARTIC ACID-N-FMOC, BETA-O-TERT-BUTYL ESTER (15N, 98%)

CLM-6855-1 LINOLEIC ACID (18:2) (U-13C18, 98%) 94%+ (<10% CIS/TRANS ISOMER)

BDE-166-CS 2,3,4,4',5,6-HEXABDE (BDE-166) 50 UG/ML IN NONANE UNLABELED CERTIFIED STANDARD

CLM-681-1 ETHYL ACETOACETATE (3-13C, 99%)

EDF-5429-CS1H TWO COLUMN DIOXIN & FURAN CALIBRATION SOLUTION CS1H (UNLABELED/13C12, 99%)

DLM-2135-1.2 BENZO[GHI]PERYLENE 97% CHEMICAL PURITY (D12, 98%) 200 UG/ML IN TOLUENE-D8

CLM-156-CTM SODIUM ACETATE (1-13C)

ULM-8081-D-1.2 TESTOSTERONE UNLABELED 100 UG/ML IN DIOXANE

EDF-5005 US EPA METHOD 8290 SAMPLE FORTIFICATION SOLUTION (13C12, 99%)

CNLM-3809-PK URIDINE (13C9, 98%; 15N2, 96-98%)

M-041 METHOHEXITAL UNLABELED 1.0 MG/ML IN METHANOL

EO-5001 4,4'-DIBDE (BDE-15) (13C12, 99%) 50 UG/ML IN NONANE

B-045 BUTYLONE HCL UNLABELED 1.0 MG/ML IN MEOH (AS FREE BASE)

DLM-194-PK DEUTERIUM HYDRIDE (D, 97%)

ULM-7413-1.2 ACENAPHTHENE UNLABELED STANDARD 200 UG/ML IN ISOOCTANE

DLM-691-PK N-HEXANOL (D13, 98%)

IRLM-3711-0 IRIDIUM-193 METAL (193Ir)

CLM-3911-PK ETHANOLAMINE·HCL (1-13C, 99%)

EC-5379-1/10X-10 EN-1948-4 MARKER PCB EXTRACTION SPIKE (13C12, 99%) 100 NG/ML IN NONANE

ERP-045 METHOD 1665 DAILY CALIBRATION SOLUTION (CS3)

DLM-8923-CA GUANOSINE 5'-TRIPHOSPHATE (GTP), NH4 SALT (RIBOSE-3',4',5',5''-D4,98%)C.P.>90%(IN SOLN)

DLM-9150-0.001 18-HYDROXYCORTICOSTERONE (9,11,12,12-D4,98%) CHEM. PURITY 95%

DLM-366-PK PERYLENE (D12, 98%)

ES-5348-CS6 POPS PESTICIDES CALIBRATION SOLUTION CS6 (UNLABELED/13C, 99%) IN NONANE

DLM-1826-PK L-GLUTAMINE (2,3,3,4,4-D5, 97%)

CLM-4589-MT-1.2 MONO-N-OCTYL PHTHALATE 100 UG/ML IN MTBE (RING-1,2-13C2, DICARBOXYL- 13C2, 99%)

更多關于的產品信息，請我司。

會員登錄

收藏該商鋪

提示